Hive ^Company

Gene sequencing and CRISPR/Cas9 technologies have enabled affordable genome mapping and editing with unprecedented precision; however, the bottleneck in understanding human disease mechanisms and bringing breakthrough therapies to patients faster now lies in the manual experimentation to introduce these new vectors into model organisms. HIVE Biosystems' rapid, self-driving instruments perform large-scale genetic modification and deep phenotyping of model organisms with deep learning algorithms.